The concept of platinum sensitivity could be applied to recurrent cervical cancer: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
Munetaka TakekumaKeita MoriTetsuji IidaKazuko KuriharaMotoaki SaitouHideki TokunagaKei KawanaMasae IkedaToyomi SatohToshiaki SaitoEtsuko MiyagiYutaka NagaiAkiko FurusawaYoshiaki KawanoKouichiro KawanoTsutomu TabataYukinobu OtaRyoji HayaseMikio MikamiToru SugiyamaPublished in: Cancer chemotherapy and pharmacology (2017)
This study showed that the concept of platinum sensitivity could be applied to recurrent cervical cancer and PFI could be one of the independent prognostic factors for patients with recurrent cervical cancer who have previously been treated with platinum-based chemotherapy.